KRAS and familial pancreatic carcinoma: Due to the difficulty in diagnosing PDAC especially in patients with CP, a separate study [7] looked at the relationship between Ca19.9 combined with KRAS mutation and suggested that in a CP patient with normal Ca19.9 levels and no KRAS mutations, the diagnosis of pancreatic cancer can be excluded with almost certainty.